OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics is a biopharmaceutical company developing firstinclass small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation..
Type
B2c
Founded
2013
Raised
$36.5M
Follow us
Alexa global traffic share
Latest funding Show all
€17,000,000
Venture capital (Series C) - 2018
High-Tech Gründerfonds The Falck Revocable Trust KFW Group +5
Undisclosed amount
Angel - 2017
Remiges Ventures
Team Size
10+
Employees
Location
Headquarters
€17,000,000 Venture capital (Series C)
FinSMEs , PE HUB

Omeicos Therapeutics Raises €17M in Series C Financing

Funding Health Science
€1,700,000 Grant
businesswire

OMEICOS Secures Continued BMBF Support with New €1.7M Research Grant to Advance its Novel Approach to Treat Cardiovascul...